Tenaya Therapeutics (TNYA)
US Market

Tenaya Therapeutics (TNYA) Financial Statements


Tenaya Therapeutics Financial Overview

Tenaya Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.719; its P/E ratio is -2.59; Tenaya Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -29.93M$ -29.14M$ -33.27M$ -33.71M$ -34.55M
EBITDA$ -25.26M-$ -30.79M$ -35.81M$ -36.65M
Net Income Common Stockholders$ -29.95M$ -29.14M$ -33.27M$ -31.74M$ -33.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 104.64M$ 121.75M$ 132.50M$ 147.81M$ 186.53M
Total Assets$ 170.51M$ 193.40M$ 220.75M$ 245.34M$ 278.94M
Total Debt$ 12.42M$ 12.04M$ 13.10M$ 14.12M$ 15.10M
Net Debt$ -92.22M$ -109.71M$ -119.40M$ -133.69M$ -171.43M
Total Liabilities$ 31.09M$ 28.51M$ 30.81M$ 29.93M$ 35.57M
Stockholders Equity$ 139.42M$ 164.88M$ 189.94M$ 215.41M$ 243.38M
Cash Flow-
Free Cash Flow$ -22.32M-$ -26.41M$ -30.52M$ -23.48M
Operating Cash Flow$ -21.92M$ -23.64M$ -26.20M$ -29.89M$ -22.68M
Investing Cash Flow$ -14.92M$ 30.49M$ 25.09M$ 8.06M$ 5.97M
Financing Cash Flow$ 371.00K-$ 4.18M$ -501.00K$ 77.49M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Tenaya Therapeutics Debt to Assets

Tenaya Therapeutics Cash Flow

Tenaya Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis